Congenital Myasthenic Syndrome due to Rapsyn Deficiency: Three Cases with Arthrogryposis and Bulbar Symptoms

Abstract

We report the cases of 3 children with postsynaptic congenital myasthenic syndrome with acetylcholine receptor deficiency due to rapsyn deficiency. Symptoms began at the neonatal period with hypotonia, arthrogryposis, bulbar symptoms, and respiratory distress. Two of the 3 children needed tracheostomy and gastrostomy. Electromyograms showed a decremental response to repetitive stimulation. Muscle biopsies were normal or showed type I fiber preponderance. Genetic studies identified mutations in the rapsyn gene (RAPSN). The 3 patients were heterozygous for N88 K and a second mutation (either Y86X, 1083_1084 dupCT or IVS4-2 A > G). The patients responded favorably to anticholinesterase treatment, with a clear improvement of clinical symptoms, especially the bulbar symptoms of apneas and swallowing disturbances. This paper underlines the importance of anticholinesterase medication in patients with congenital myasthenic syndrome due to rapsyn deficiency.

Key words

Congenital myasthenic syndrome - rapsyn - arthrogryposis

References

• 1 Beeson D, Palace J, Vincent A. Congenital myasthenic syndromes.  Curr Opin Neurol. 1997;  10 402-407
• 2 Brownlow S, Webster R, Croxen R, Brydson M, Neville B, Lin J-P. et al . Acetylcholine receptor δ subunit mutations underline a fast-channel myasthenic syndrome and arthrogryposis multiplex congenital.  J Clin Invest. 2001;  108 125-130
• 3 Burke G, Cossins J, Maxwel S, Owens G, Vincent A, Robbs S. et al . Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.  Neurology. 2003;  61 826-828
• 4 Dunne V, Maselli R A. Identification of pathogenic mutations in the human rapsyn gene.  J Hum Genet. 2003;  48 204-207
• 5 Engel A G, Ohno K, Sine S M. Congenital myasthenic syndromes. Engel AG Myasthenia Gravis and Myasthenic Disorders. New York; Oxford University Press 1999: 251-297
• 6 Engel A G, Ohno K, Sine S M. Congenital myasthenic syndromes: progress over the past decade.  Muscle Nerve. 2003;  27 4-25
• 7 McConville J, Vincent A. Diseases of the neuromuscular junction.  Curr Opin Pharmacol. 2002;  2 296-301
• 8 Maselli R A, Dunne V, Pascual-Pascual S I, Bowe C, Agius M, Frank R. et al . Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.  Muscle Nerve. 2003;  28 293-301
• 9 Müller J S, Mildner G, Müller-Felber W, Schara U, Krampfl K, Petersen B. et al . Rapsyn N88 K is a frequent cause of congenital myasthenic syndromes in European patients.  Neurology. 2003;  60 1805-1810
• 10 Ohno K, Engel A G, Shen X-M, Selcen D, Brengman J, Harper C M. et al . Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.  Am J Hum Genet. 2002;  70 875-885
• 11 Ohno K, Sadeh M, Blatt I, Brengman J M, Engel A G. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.  Hum Mol Genet. 2003;  12 739-748
• 12 Richard P, Gaudon K, Andreux F, Yasaki E, Prioleau C, Bauché S. et al . Possible founder effect of rapsyn N88 K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.  J Med Genet. 2003;  40 1-5